Publications by authors named "Richard Le"

Claim this Profile
I
Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future.
James P Psaltis, Jessica A Marathe, Mau T Nguyen, Richard Le, Christina A Bursill

Med Res Rev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs.
Richard Le, Mau T Nguyen, Momina A Allahwala, James P Psaltis, Chinmay S Marathe

J Clin Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis.
Nathan K P Wong, Emma L Solly, Richard Le, Victoria A Nankivell, Jocelyne Mulangala

Int J Mol Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Mortality Outcomes in Real-world Patients with Lean, Nonobese, and Obese Nonalcoholic Fatty Liver Disease.
Vy H Nguyen, Audrey Ha, Nicholas Ajit Rouillard, Richard Hieu Le, Ashley Fong

J Clin Transl Hepatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study.
Vy H Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong

Clin Mol Hepatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis.
Michael H Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Richard H X Le, David M Le

Clin Gastroenterol Hepatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice.
Hidenori Toyoda, Jennifer Leong, Charles Landis, Masanori Atsukawa, Tsunamasa Watanabe, Richard H Le

Hepatology· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis.
Changqing Zhao, Feng Xing, Yee Hui Yeo, Michelle Jin, Richard Le, Michael Le

Eur J Gastroenterol Hepatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue.
Changqing Zhao, Mingjuan Jin, Richard Hieu Le, Michael Huan Le, Vincent Lingzhi Chen, Michelle Jin

Liver Int· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary embolectomy: should it be offered earlier rather than later?
Richard D Le, Naresh A Dewan

Respir Care· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis